NASDAQ
IGM Biosciences, Inc. (IGMS) has a free cash flow growth of -56.04% as of Friday, May 29, 2026. This represents a 845.07% decrease compared to its 12-month average of 7.52%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.